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Abstract Malaria parasite digests hemoglobin and utilizes the 
globin part for its nutritional requirements. Heme released as a 
byproduct of hemoglobin degradation is detoxified by polymer-
ization into a crystalline, insoluble pigment, known as hemozoin. 
We have identified a novel reaction of depolymerization of 
hemozoin to heme. This reaction is initiated by the interaction of 
blood schizonticidal antimalarial drugs with the malarial 
hemozoin. The reaction has been confirmed, with the purified 
hemozoin as well as the lysate of the malaria parasite. Pigment 
breakdown was studied by infrared spectroscopy, thin-layer 
chromatography and spectrophotometric analysis. It was com-
plete within 2 h of drug exposure, which explains the selective 
sensitivity of late stages (trophozoites and schizonts) of malarial 
parasites loaded with the hemozoin pigment to the toxic action of 
these drugs. It is suggested that the failure of the parasite heme 
detoxification system due to this reaction results in the 
accumulation of toxic heme, which alone, or complexed with 
the antimalarial leads to the death of malaria parasite. 
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1. Introduction 
Malaria is a disease of global concern with around 300-500 
million cases per year and a populat ion of more than 2400 
million at risk of infection. The continuous proliferation and 
cyclic propagation of malaria parasite inside erythrocytes are 
distinct features of malaria infection and are chiefly responsi-
ble for the pathophysiology of the disease. Hemoglobin, the 
major protein available in erythrocytes, is utilized as a source 
of nutrition by the parasite. Digestion of hemoglobin by ma-
laria parasite involves a specific sequence of reactions through 
the action of aspartic as well as cystine proteases and leads to 
the continuous release of toxic free heme [1^1]. However, 
simultaneous detoxification and sequestration of heme to an 
insoluble, crystalline, black-brown pigment named 'hemozoin' 
prevents the accumulation of free heme [5-7]. Malarial hemo-
zoin has been characterized as a polymer of heme units linked 
through an iron-carboxylate bridge [8]. The molecular mech-
anisms of initiation and continuous polymerization of heme to 
hemozoin in the malaria parasites are still under debate. The 
involvement of a parasite specific heme polymerase activity in 
the catalysis of hemozoin formation reported earlier [9-11] 
has recently been questioned [12,13]. A previous report of 
heme polymerization activity associated with purified hemo-
zoin/ß-hematin [14] was later attributed to a phospholipid 
fraction [15]. However, a histidine-rich protein ( H R P II) has 
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recently been localized in the digestive vacuole of malaria 
parasite which provides a nucleus for the polymerization of 
heme [16], supporting the theory that the involvement of some 
parasitic component is necessary for hemozom formation. 
Very recently, we have shown that hemozoin formation under 
physiological conditions cannot occur chemically in the ab-
sence of any parasite derived component [17]. 
The sensitivity of malaria parasites to several antimalarial 
drugs including the most popular drug chloroquine is confined 
to the parasite stages that actively degrade hemoglobin and 
accumulate hemozoin [18]. Blood schizonticidal antimalarial 
drugs have a selectively fast toxic action on the trophozoite 
and schizont stages of the parasite which are heavily laden 
with hemozoin. These stages are subjected to the toxic effect 
of blood schizonticidal drugs within 2-A h of exposure. Ring 
stage parasites have heme polymerization activity, but are 
relatively insensitive to the toxic effects of these drugs (action 
time > 12 h) [19]. This indicates that the presence of pre-
formed hemozoin may be necessary for the selective antima-
larial action of blood schizonticidal drugs. Thus, inhibition of 
heme polymerization alone as suggested earlier [5] cannot ex-
plain the selective antimalarial action of these drugs. 
In this communication, we describe a novel biochemical 
mode of blood schizonticidal action of the antimalarials 
through the breakdown of preformed hemozoin. 
2. Materials and methods 
2.1. Purification and characterization of hemozoin 
Hemozoin was purified from mouse blood highly infected (para-
sitemia 50-70%) with Plasmodium yoelii according to a method re-
ported earlier [20]. The purity of hemozoin was ascertained by infra-
red spectroscopy, and spectrophotometric and elemental analysis [20]. 
2.2. Depolymerization assay 
The hemozoin depolymerization (breakdown) assay was developed 
on the basis of the differential solubility of hemozoin and heme [6]. 
Hemozoin was suspended in acetate buffer (pH 5.0, 500 mM) and 
mildly sonicated to obtain a suspension of fine crystals of the pigment. 
The pigment was incubated with varying concentrations of chloro-
quine. The total volume of the incubation mixture was 1.0 ml and 
incubation was continued for at least 10 h (or as specified) in a shak-
ing water bath at 37°C. The suspensions were centrifuged at lOOOOXg 
for 10 min and the pellets were washed twice with distilled water and 
finally with bicarbonate buffer (100 mM, pH 9.5). Heme is soluble in 
bicarbonate buffer while hemozoin is not soluble [6]. The pellet of the 
remaining hemozoin was dissolved in 2.0 N NaOH to convert it into 
heme (ferriprotoporphyrin IX) and quantitated (as equivalent of 
heme) by recording the spectra of ferriprotoporphyrin IX (FP IX) 
in the range of 360-700 nm [21]. In some of the initial experiments 
the heme released in the bicarbonate wash was also quantitated. How-
ever, the quantitation of heme released could not be employed as a 
routine procedure for the assay of hemozoin breakdown/depolymeri-
zation. After incubation the complete separation of hemozoin and 
heme may only be achieved by repeated washings with 2.5% SDS 
and bicarbonate buffer. This makes the estimation of heme in the 
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pooled washings difficult and leads to low sensitivity of the assay. 
Moreover, in the experiments conducted with the lysates of malaria 
infected erythrocytes, the large amount of heme is present as a part of 
hemoglobin and other proteins make the estimation of heme released 
due to hemozoin breakdown extremely difficult. Therefore, a reverse 
assay was standardized based on the estimation of hemozoin in the 
form of ferriprotoporphyrin IX (FP IX) equivalents after converting it 
into its constituent heme units by alkali solubilization [8]. The amount 
of hemozoin depolymerized was calculated by subtracting the hemo-
zoin remaining after incubation with the drug from the amount of 
hemozoin in control tubes (without any drug) run simultaneously. For 
depolymerization assay with the P. yoelii infected erythrocyte lysate, 
the blood in acid-citrate-dextrose was washed three times with phos-
phate-buffered saline and the pellet was finally suspended in 2 vols. of 
acetate buffer (500 mM, pH 5.0). 100 JJ.1 each of the lysate was dis-
pensed into different tubes and the final volume of the incubation 
mixture was adjusted to 1 ml. The mixture was incubated at 37°C 
for 2 h (or as specified) in a shaking water bath with various concen-
trations of chloroquine. The assay mixture was centrifuged at 
lOOOOXg for 10 min and the remaining hemozoin was estimated in 
the pellets after washing three times with 2.5% (w/v) SDS and once 
with bicarbonate buffer (pH 9.5, 100 mM). Quinoline drugs are 
known to accumulate in the food vacuole of the malaria parasite 
[5]. Hence, the drug concentrations used in these experiments are 
the effective concentrations at the physiological site of pigment for-
mation. Similar drug concentrations have previously been tested to 
study the inhibition of heme polymerization [5,9-11,14,16]. 
3. Results and discussion 
Chloroquine (chloroquine) has previously been shown to 
inhibit the polymerization of heme to hemozoin [5,9-11]. 
We have been trying to study the molecular and physico-
chemical mechanism(s) of this effect. During analysis of the 
effect of chloroquine on heme polymerization activity in vitro, 
it was observed that in the control assay mixtures containing 
the extract of malaria parasite and chloroquine only (without 
heme substrate) the level of preformed hemozoin decreased 
significantly as compared to the assay mixtures containing 
the parasite extracts only (no drug controls). Further, incuba-
tion of chloroquine with the purified hemozoin yielded a 
product with the characteristic spectrum of heme or ferripro-
toporphyrin IX on spectrophotometric analysis. This provided 
us with the clue that chloroquine directly interacts with he-
mozoin and results in its breakdown. In order to confirm 
these observations, a series of experiments were performed 
with the purified malarial hemozoin. Incubation of purified 
hemozoin with chloroquine in acetate buffer (pH 5.0) resulted 
in a concentration-dependent decrease in the level of hemo-
zoin with concomitant release of heme from the pigment (Fig. 
1 A). The breakdown product of this reaction was identified as 
ferriprotoporphyrin IX by infrared spectroscopy and spectro-
photometric analysis as well as by thin-layer chromatography 
[22]. The infrared spectra of the malarial hemozoin show char-
acteristic absorbance peaks at 1660 and 1207 cm - 1 . These 
absorbance peaks have been assigned to iron-carboxylate link-
age between heme sub-units and ensure the polymeric nature 
of the malaria pigment [8]. However, the IR spectra of the 
breakdown product released due to interaction of chloroquine 
with malarial hemozoin were similar to that of heme and the 
absorbance peaks characteristic of hemozoin as mentioned 
above were absent. These observations clearly establish that 
interaction of chloroquine with the malarial hemozoin ini-
tiates a reverse reaction of conversion of hemozoin to mono-
meric heme (ferriprotoporphyrin IX). The reaction was there-
fore termed 'hemozoin depolymerization'. The reaction was 
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Fig. 1. Effect of chloroquine in vitro on purified hemozoin. (A) At 
varying concentration of chloroquine and (B) a time course study. 
Results are presented as mean ± S.D. of at least three experiments. 
complete within 2 h of incubation of hemozoin with chloro-
quine (Fig. 1 B). A similar effect was observed if, instead of 
purified hemozoin, lysate of erythrocytes infected with Plas-
modium yoelii was incubated with chloroquine (Fig. 2A). A 
time-dependent decrease in the pigment concentration was 
observed in the samples containing chloroquine. The lysate 
incubated without the drug did not show any change in the 
level of hemozoin indicating that during this period there was 
no detectable formation of de novo hemozoin (Fig. 2B). The 
decrease in hemozoin level in the presence of chloroquine 
under these conditions was therefore due to depolymerization 
of preformed hemozoin rather than the inhibition of hemo-
zoin formation by chloroquine. A similar depletion in the 
content of hemozoin was also observed when a suspension 
of intact P. yoelii infected erythrocytes was incubated with 
chloroquine (data not shown). The effect of various factors 
was also studied on depolymerization of purified hemozoin by 
chloroquine(Fig. 3). Inclusion of bovine serum albumin in the 
incubation mixture was found to have no effect on the reac-
tion, but a high concentration of free heme ( > 20 iiM) was 
inhibitory to the chloroquine-induced hemozoin breakdown 
(Fig. 3A). The reaction was favored at the pH corresponding 
to that of the parasite food vacuole, i.e. pH 4.5-5.0 (data not 
shown). Depolymerization of hemozoin by chloroquine was 
also dependent on the initial concentration of hemozoin (Fig. 
3B). Efficiency of the reaction (in terms of percentage depo-
lymerization) decreased as hemozoin concentration increased. 
A feed-back effect by the heme released due to the reaction 
may be responsible for this effect. Other antimalarial drugs 
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that caused depolymerization of hemozoin include quinine, 
quinacrine, quinaldine, amodiaquin, mefloquin and halofan-
trine. Primaquine (a tissue schizonticidal antimalarial), pyri-
methamine (a potent inhibitor of malarial dihydrofolate re-
ducíase) and desferrioxamine (a ferric iron chelator used in 
antimalarial chemotherapy) did not show this effect (Fig. 4). 
It has been observed for a long time that the blood schiz-
onticidal activity of antimalarial drugs of the 4-aminoquino-
line class (e.g. chloroquine, quinine etc.) depends upon active 
hemoglobin degradation by the parasite and subsequent for-
mation of hemozoin in the parasite food vacuole, the site of 
hemoglobin degradation [23]. A chloroquine-resistant strain 
of malarial parasite that produces little or no hemozoin re-
verts to hemozoin production upon reverting to chloroquine 
susceptibility [24]. In many other chloroquine-resistant strains 
where hemozoin is normally produced, the drug resistance has 
been correlated with less accumulation of the drug inside the 
parasite digestive vacuole [18]. The malaria parasites treated 
with chloroquine show clumping of the hemozoin pigment 
[25]. These indicate that the presence of preformed hemozoin 
is necessary for selective antimalarial action of these drugs. 
The reaction we have described herein explains this require-
ment. 4-Aminoquinoline antimalarial drugs are known to ac-
cumulate in the food vacuole of the malaria parasite [26-32] 
and form complexes with heme [33-36]. Two major mecha-
nisms are suggested for the accumulation of chloroquine and 
related drugs inside the malarial food vacuole. One is a weak 
base mechanism; according to it, the chloroquine becomes 
protonated inside the acidic food vacuole, which makes it 
LÜ 
Z 
~u 
HZ remaining A 
Hz depolymerized ; 
CQ+BSA(1.0mg/ml) 
CQ+BSA(0.5mg/ml) 
CQ+BSA(0.1mg/mi) 
CQ+Hemin(200(/M) 
CQ+Hemin(100(/M) 
CQ+Hemm(20jjM) 
CQ+Hemin(10yM) 
CQ(lmM) 
0 5 1 1.5 2 2.5 
HEMOZOIN DEPOLYMERIZED 
(EQUIVALENT TO n mol of HEME) 
Control 0.01 0.05 0.10 0.50 1.00 
CQ CONCENTRATION (mM) 
5.00 
0 1 2 3 4 5 6 
INITIAL Hz CONCENTRATION 
(EQUIVALENT TO n mol OF HEME) 
Fig. 3. Effect of heme, bovine serum albumin and hemozoin concen-
tration on depolymerization of hemozoin by chloroquine. (A)Bovine 
serum albumin and heme and (B) varying concentration of hemo-
zoin (dotted line, nmol of hemozoin (equivalent to heme) depolym-
erized; solid line, % depolymerization). Each bar/point represents 
the value mean ± S.D. of at least triplicate observations. 
unable to cross the membrane again and therefore it becomes 
concentrated as a result of constant influx. Heme has also 
been identified as a receptor as it forms a complex with chlo-
roquine [23]. A heme-chloroquine complex would not be able 
to cross the vacuolar membrane and hence leads to drug ac-
cumulation [37,38]. Alternatively, a chloroquine-binding pro-
tein has also been identified [37]. The efficacy of quinoline 
drugs may be attributed to their property of accumulation 
in the malarial food vacuole which results in their effective 
concentration being several orders of magnitude greater 
than their therapeutic concentrations. Interaction of these 
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Fig. 2. Effect of chloroquine in vitro on hemozoin content of Plas-
modium yoelii infected erythrocyte lysate. (A) At varying concentra-
tion of chloroquine and (B) a time course study. Results are pre-
sented as mean ± S.D. of at least triplicate observations. 
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Fig. 5. Biochemical mode of blood schizonticidal action of chloroquine 
tion function of malaria parasite. 
drugs with the malaria pigment may start a process of molec-
ular rearrangement responsible for depolymerization of the 
pigment. 
We did not observe hemozoin depolymerization by chloro-
quine when synthetic ß-hematin (prepared by incubating hem-
atin in 5 M acetate at 80°C for 12 h) [8] was used in place of 
hemozoin isolated from the malaria parasites. Structural dif-
ferences between chemically synthesized ß-hematin and the 
malarial hemozoin in terms of average number of heme sub-
units involved in the formation of the polymer (hemozoin/ß-
hematin) may be the reason for this anomaly. However, no 
experimental approach may de designed for determining the 
average molecular size of malarial hemozoin/ß-hematin. 
Formation of hemozoin by the malaria parasite is a slow 
process which is associated with the degradation of hemoglo-
bin starting at the ring stage and continues up to the late 
trophozoites. Inhibition of this process alone may not explain 
the rapid action time ( < 2 h) of the blood schizonticides, since 
the heme accumulated as a result of inhibition of heme polym-
erization alone may not be sufficient to produce cytotoxic 
action. Moreover, vacuolar proteases responsible for the deg-
radation of hemoglobin and generation of heme are also in-
hibited by chloroquine, thereby restricting the availability of 
heme after the drug treatment. On the basis of the results 
presented here, we propose that blood schizonticidal antima-
larial drugs not only interfere with hemozoin formation as 
reported earlier [5] but also cause depolymerization of the 
hemozoin already present in the parasite food vacuoles prior 
to drug treatment. Their activity may be attributed to the 
targeting of malaria pigment, converting it back to toxic 
heme, thus resulting in a total collapse of the parasite heme 
detoxification system. Release of heme may further initiate the 
inhibition of vacuolar proteases responsible for hemoglobin 
degradation by the parasite and exert other toxic effects [39-
42]. These results may therefore explain the specific require-
ment for the presence of the hemozoin pigment for selective 
and other related antimalarials through interruption of heme detoxifica-
blood schizonticidal action of a wide variety of antimalarial 
drugs. Based on the information accumulated to date, a 
scheme has been proposed for the mechanism of the blood 
schizonticidal action of chloroquine and other related antima-
larials (Fig. 5). Further studies on the structural and mecha-
nistic aspects of this reaction may reveal information which 
could be utilized for the designing of better antimalarial drugs 
for which the need is pressing due to the rapidly spreading 
resistance to commonly used antimalarial drugs. Exploitation 
of this reaction may also help to expedite the clearance of the 
pigment sequestered in the tissues of the infected host [43], a 
major factor responsible for the hepatic and splenomegaly 
which persists for quite some time even after curing of the 
parasite burden. 
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